FUTURE OF HEALTHCARE
Solera Health | June 16, 2022
Leading personalized health solutions platform, Solera Health announced that it has added DarioHealth to its cardiometabolic network to offer hypertension management solutions.
"Chronic conditions like hypertension can be difficult to manage, especially when in conjunction with multiple other diseases or symptoms. According to the CDC, nearly half of adults in the U.S. experience high blood pressure, and the prevalence increases with age. We are thrilled to expand Solera's offerings to patients with this condition through our partnership with Dario, as well as continue strengthening relationships with our health plan partners by empowering them to offer accessible, best-in-class digital health solutions."
Mary Langowski, CEO, Solera
Cardiometabolic conditions comprise both cardiovascular and metabolic disorders such as hypertension, diabetes, and obesity.
Dario delivers a personalized solution through the use of medical devices, next-generation technologies, and smartphone applications in order to boost customers’ commitment to healthy living.
"We are excited to partner with Solera and share our digital hypertension solutions with their payer and employer clients. Dario is committed to improving access and quality of care for individuals with hypertension by expanding the reach of our highly personalized solutions. This collaboration with Solera expands our ability to reach patients and continue our mission of transforming care for people with chronic conditions."
Rick Anderson, President & General Manager, North America of DarioHealth
MindMed | July 12, 2021
MindMed, a leading biotech firm developing psychedelic-inspired therapies, and Datavant, Inc., a leader in assisting healthcare organizations in safely connecting their data, announced a collaboration in which MindMed will use Datavant's privacy-protecting technology to link MindMed's clinical trial data to external data from both clinical and real-world sources. In addition, MindMed intends to use Datavant's connecting technology across the drug lifecycle, including discovery, clinical development, and commercialization.
MindMed will create broad and comprehensive datasets via data linking to understand better the real-world treatment, service usage, and healthcare experiences of patients with psychiatric and drug use disorders. This data, as well as a better understanding of both the relevant illness and the pathways of treatment that patients take, will assist MindMed's clinical trial planning, execution, and preparation for commercialization of its novel molecules.
MindMed is a clinical-stage biotech company that discovers, develops, and sells psychedelic-inspired medicines and therapies to treat addiction and mental disease. The company is building a compelling drug development pipeline of novel treatments based on psychedelic drugs such as psilocybin, LSD, MDMA, DMT, and 18-MC, an ibogaine derivative. MindMed's executive team brings extensive biopharmaceutical expertise to the company's approach to creating the next generation of psychedelic-inspired medicines and therapies.
The goal of Datavant is to connect the world's health data to enhance patient outcomes. Datavant aims to minimize the friction associated with data sharing in the healthcare sector by developing the technology that preserves patients' privacy while allowing the linkage of de-identified patient records across datasets. Datavant is based in San Francisco.
Surgio | December 01, 2021
Surgio Health, a leading healthcare software platform targeting instrument tracking and optimization solutions, has partnered with DARVIS (Data Analytic Real-World Visual Intelligence System), a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. Together, the two are diving into creating innovative instrument tracking and optimization solutions utilizing optical recognition and machine learning technology.
DARVIS is a productivity as a service platform (PaaS) that digitizes objects and processes through AI-powered computer vision technology, enabling it to provide real-time analysis of environments and situations. With the use of computer vision technology, healthcare providers can now easily track objects such as surgical instruments, no matter how small. This allows for tracking and optimization down to the instrument level without the need to individually tag each item.
Surgio Health is a software as a service platform (SaaS) that provides a fully integrated digital transformation of surgical asset management and optimization for the operating room (OR) and sterile processing department (SPD). With Surgio, facilities can easily locate surgical instruments, ensure proper sterilization steps are taken, coordinate with vendors for loaned and consigned instrument sets, and use interactive analytics to reduce costs and improve productivity.
Using DARVIS's computer vision technology, the two will be able to incorporate the use of AI tracking cameras with Surgio's innovative and in-depth tracking software. With the creation of this partnership, the OR and SPD will be able to manage and optimize their sterilization costs, staffing models, and case readiness.
"DARVIS is thrilled to join forces with Surgio to bring the next age of innovation to healthcare. Our Inventory Tracker platform adds visibility to Surgio's robust existing tracking software. The Inventory Tracker solution can track surgery kits and scopes throughout the equipment's entire lifecycle. This directly translates to immediate boosts in efficiency standards and cost savings." - Jan Schlueter, COO, DARVIS
"Surgio is very excited to partner with DARVIS for the development of transformative Artificial Intelligence through optical recognition and machine learning solutions. Together we will bring actionable data insights that provide real-time visibility and predictability of surgical equipment and staffing optimization to the OR and SPD departments."
Chris J. Stewart, CEO, Surgio Health
Instrument level tracking becomes even easier with machine learning. Eliminating the need to tag individual instruments makes implementation painless and cost-effective for any hospital system. Surgio and DARVIS will begin by tracking endoscopes, which are often one of the most challenging—and costly—instruments to track and sterilize effectively, with undetectable bioburden frequently remaining in tough-to-clean areas. Through DARVIS's visual tracking system, Surgio can ensure that these scopes are systematically sterilized properly, without additional work being placed on employees.
Together, DARVIS and Surgio want to eliminate patient safety risks and unnecessary processing costs related to sterilization, while simplifying process and workflow for hospitals and their staff. Currently, the two companies plan to release their first partnership solution in 2022.
Surgio Health is a surgical instrument management technology partner for healthcare facilities and medical device manufacturers. Surgio delivers an innovative suite of solutions that drive alignment between OR, sterile processing department (SPD), surgeons, and vendors to lower costs, mitigate risk, and improve efficiencies. Our surgical instrument tracking & optimization, vendor performance management, and manufacturer & distributor asset management solutions follow HIPAA guidelines and are EHR/ERP integrated. Founded in 2015, the company is based in Scottsdale, Arizona.
DARVIS (Data Analytic Real-World Visual Intelligence System) is a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. DARVIS solutions help transform hospitals and healthcare organizations into intelligent autonomous environments that enable healthcare professionals to deliver better and safer patient-centric care. Founded in 2015, the company is based in Nashville, Tennessee.